TKB Critical Technologies 1 (NASDAQ:USCT) announced a series of moves this morning that include terminating their combination with Wejo (OTC:WEJOQ), selling sponsor economics and postponing today’s extension meeting to 11:30 am ET June 28.
It comes as little surprise that the SPAC terminated its combination with Wejo, which completed an earlier SPAC deal with Virtuoso in 2021, but filed for insolvency in the UK last month. In recent months, it had been de-listed from the Nasdaq and its market cap had fallen below $2 million as of June 23.
TKB I has also agreed to sell much of its sponsor economics to Roth Capital Partners and Craig-Hallum Capital Group for an aggregate purchase price of just $1. These buyers are to receive 4,312,500 total shares including 75,000 promote shares and 8,062,500 of TKB I’s 10,750,000 private placement warrants.
In connection with the transfer, the SPAC’s full management team is set to resign. Roth and Craig-Hallum are to contribute $31,000 to the sponsor to pay outstanding invoices, $300,000 for certain liabilities and the incoming buyers are to be responsible for contributing the lesser of $60,000 or $0.03 per share for TKB I’s upcoming extension vote.
The SPAC has already postponed this vote, which would have taken place today, and TKB I’s redemption deadline has been extended to 5 pm ET today should any shareholder wish to reverse their decisions.
The extension proposal would allow TKB I to extend its deadline up to 16 times monthly up to October 29, 2024. So, an approval would give a new team a wide timeframe to execute a new deal.
April is set to be a less-eventful month for SPAC dealmakers seeing their shares unlocked, but the activity does start already tomorrow. The sponsor of Excelfin is set to see its promote shares in Baird Medical (NASDAQ:BDMD) come available to trade on April 1. It is one of just two sponsors being released this month...
At the SPAC of Dawn Two SPACs have scheduled shareholder votes for this week including Bukit Jalil 1‘s (NASDAQ:BUJA) special meeting to approve its combination with Global IBO Group later today. The SPAC still has about half of its $50 million trust in tact going into the vote and Global IBO’s core business of providing...
Terms Tracker for the Week Ending March 28, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. No SPAC IPOs priced this week, which means March closes out with just two IPOs total, both of which priced last week. By comparison, January...
At the SPAC of Dawn The year’s first big IPO has arrived, and its wings have already been trimmed before it got out the gate. AI chip firm CoreWeave had been aiming to price at a range of $47 to $55 per share, which would have valued the company at $26.5 billion at the top...
At the SPAC of Dawn Another day, another wave of trade war news as US President Donald Trump has announced fresh 25% tariffs on all imported automobiles on April 3 in addition to the new customs duties expected to come into force on April 2. These moves cut across a wide swath of SPAC target...